http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-506623-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5936926c3afd073c2ecb0d32dbe52aa0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_676b80da7ac92b84e447a83fb1630ae1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
filingDate 1999-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db4b9753d59c10de03ee6b2bc6fbcc19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7cb7663d90ac4ba031e39b0b607d85d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_341a882a3ca8ba74bb148ea053ccc97f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a180a5ff016fdb30fa70bb67e72ca8f
publicationDate 2002-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-506623-A
titleOfInvention Acylated betulin and dihydrobetulin derivatives, preparation thereof and use in treatment of retroviral infections
abstract A compound of Formula (l) or its salt for use in treating HIV infection, wherein: R1 is a C2-C20 optionally substituted carboxyacyl, R2 is a C2-C20 optionally substituted carboxyacyl; and R3 is hydrogen, halogen, amino, optionally substituted mono-or di-alkylamino, or-OR4; R4 is hydrogen, C1-4 alkanoyl, benzoyl, or C2-C20 optionally substituted carboxyacyl; the dashed line represents an optional double bond between C20 and C29; and provided that when R3 is hydrogen, then R1 and R2 are both succinyl, maleyl, fumaroyl or glutaryl.
priorityDate 1998-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456166450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53627945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457673752
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423390558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456061589

Total number of triples: 34.